Patterns of opioid dispensing and associated wage replacement duration in workers with accepted claims for low back pain: a retrospective cohort study.
Journal
Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
received:
30
10
2020
accepted:
08
11
2021
pubmed:
21
11
2021
medline:
20
7
2022
entrez:
20
11
2021
Statut:
ppublish
Résumé
This study aimed to identify patterns of opioid dispensing in Australian workers with low back pain (LBP) and determine the association of dispensing patterns with wage replacement duration. Australian workers' compensation claimants with LBP and at least 1 day of wage replacement were included. We used group-based trajectory modelling to identify opioid dispensing patterns over a two-and-a-half-year period from reported LBP onset and quantile regression to compare wage replacement duration between each dispensing pattern group. Opioids were dispensed to one-third of workers with LBP (N = 3205, 33.3%) at least once during their claim. Three dispensing patterns were identified. Most had a short-term low-volume opioid dispensing pattern (N = 2166, 67.6%), whereas 798 (24.9%) had a long-term moderate-volume pattern and 241 (7.5%) had a long-term high-volume pattern. Workers with dispensed opioids had significantly longer wage replacement duration than those without dispensed opioids (median [weeks]: 63.6 vs 7.1, respectively). In addition, moderate-volume and high-volume long-term dispensing groups had significantly longer wage replacement duration compared with the short-term dispensing group (median [weeks]: 126.9, 126.0, and 30.7, respectively). Without controlling for pain severity, these results offer limited evidence that opioids lead to longer wage replacement duration. Further research controlling for pain severity, psychosocial factors, and recovery expectations is required to confirm whether the relationship between opioid dispensing pattern and wage replacement duration is causal in nature.
Identifiants
pubmed: 34799531
doi: 10.1097/j.pain.0000000000002539
pii: 00006396-202208000-00013
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e942-e952Informations de copyright
Copyright © 2021 International Association for the Study of Pain.
Références
Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med 2016;176:958–68.
Agency for Clinical Innovation (ACI). Management of people with acute low back pain. Chatswood, Australia: ACI, 2016.
Asfaw A, Quay B, Chang C-C. Do injured workers receive opioid prescriptions outside the workers' compensation system?: the case of private group health insurances. J Occup Environ Med 2020;62:e515–22.
Atlas SJ, Tosteson TD, Blood EA, Skinner JS, Pransky GS, Weinstein JN. The impact of workers' compensation on outcomes of surgical and nonoperative therapy for patients with a lumbar disc herniation: sport. Spine 2010;35:89–97.
Australian Bureau of Statistics (ABS). 2006 RA from 2006 POA correspondence. Australian standard geographical classification (ASGC) remoteness area correspondences. Canberra, Australia: Australian Bureau of Statistics, 2011.
Australian Bureau of Statistics (ABS). Australian and New Zealand standard classification of occupations, 2013, Version 1.2. Canberra, Australia: Australian Bureau of Statistics, 2013.
Australian Bureau of Statistics (ABS). Postal area, indexes, SEIFA 2011. Census of population and housing: socio-economic indexes for areas (SEIFA), Australia, 2011. Canberra, Australia: Australian Bureau of Statistics, 2013.
Australian Bureau of Statistics (ABS). 6202.0—labour force, Australia, Nov 2015. Canberra, Australia: Australian Bureau of Statistics, 2015.
Australian Government Department of Health. National real time prescription monitoring (RTPM). Vol. 2020. Canberra, Australia: Australian Government, 2019.
Australian Government Department of Health. Schedule of pharmaceutical benefits. Canberra, Australia: Department of Health, 2019.
Australian Government Department of Health Therapeutic Goods Administration. Final decisions and reasons for decisions by delegates of the secretary to the Department of Health. Canberra, Australia: Australian Government Department of Health, 2017.
Australian Government Department of Health Therapeutic Goods Administration. Prescription opioids: what chanegs are being made and why. Vol. 2020. Canberra, Australia: Australian Government Department of Health, 2020.
Australian Institute of Health and Welfare (AIHW). Opioid harm in Australian and comparisons between Australia and Canada. Canberra, Australia: AIHW, 2018.
Australian Safety and Compensation Council (ASCC). Type of occurrence classification system (third edition, revision one). Canberra, Australia: ASCC, 2008.
Bellera CA, MacGrogan G, Debled M, de Lara CT, Brouste V, Mathoulin-Pélissier S. Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC Med Res Methodol 2010;10:20.
Ben-Shalom Y, McIntyre M, Pu J, Shenk M, Zhu W, Shaw W. Workers' compensation and the opioid epidemic—state of the field in opioid prescription management. Washington DC: Mathematica, 2020.
Bohm K, Schmid A, Gotze R, Landwehr C, Rothgang H. Five types of OECD healthcare systems: empirical results of a deductive classification. Health Pol (Amsterdam, Netherlands) 2013;113:258–69.
Buchbinder R, Underwood M, Hartvigsen J, Maher CG. The Lancet Series call to action to reduce low value care for low back pain: an update. PAIN 2020;161:S57–S64.
Busse JW, Ebrahim S, Heels-Ansdell D, Wang L, Couban R, Walter SD. Association of worker characteristics and early reimbursement for physical therapy, chiropractic and opioid prescriptions with workers' compensation claim duration, for cases of acute low back pain: an observational cohort study. BMJ Open 2015;5:e007836.
Carnide N, Hogg-Johnson S, Côté P, Irvin E, Van Eerd D, Koehoorn M, Furlan AD. Early prescription opioid use for musculoskeletal disorders and work outcomes: a systematic review of the literature. Clin J Pain 2017;33:647–58.
Carnide N, Hogg-Johnson S, Koehoorn M, Furlan AD, Côté P. Relationship between early prescription dispensing patterns and work disability in a cohort of low back pain workers' compensation claimants: a historical cohort study. Occup Environ Med 2019;76:573–81.
Chu LF, D'Arcy N, Brady C, Zamora AK, Young CA, Kim JE, Clemenson AM, Angst MS, Clark JD. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain. PAIN 2012;153:1583–92.
Cifuentes M, Powell R, Webster B. Shorter time between opioid prescriptions associated with reduced work disability among acute low back pain opioid users. J Occup Environ Med 2012;54:491–6.
Collie A, Di Donato M, Iles R. Work disability in Australia: an overview of prevalence, expenditure, support systems and services. J Occup Rehabil 2019;29:526–39.
Collie A, Lane TJ, Hassani-Mahmooei B, Thompson J, McLeod C. Does time off work after injury vary by jurisdiction? A comparative study of eight Australian workers' compensation systems. BMJ Open 2016;6:e010910.
Department of Health, Aged Care. Measuring remoteness: accessibility/remoteness index of Australia (ARIA) revised edition. Occasional papers: new series number 14. Canberra: Department of Health and Aged Care, 2001.
Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ 2015;350:g6380.
Di Donato M, Buchbinder R, Iles R, Gray S, Collie A. Comparison of compensated low back pain claims experience in Australia with limb fracture and non-specific limb condition claims: a retrospective cohort study. J Occup Rehabil 2021;31:175–84.
Di Donato M, Iles R, Lane T, Buchbinder R, Collie A. The impact of income support systems on healthcare quality and functional capacity in workers with low back pain: a realist review. PAIN 2020;161:2690–2709.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain. MMWR Recomm Rep 2016;65:1–49.
Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, Ferreira PH, Fritz JM, Koes BW, Peul W, Turner JA, Maher CG, Buchbinder R, Hartvigsen J, Cherkin D, Foster NE, Maher CG, Underwood M, van Tulder M, Anema JR, Chou R, Cohen SP, Menezes Costa L, Croft P, Ferreira M, Ferreira PH, Fritz JM, Genevay S, Gross DP, Hancock MJ, Hoy D, Karppinen J, Koes BW, Kongsted A, Louw Q, Öberg B, Peul WC, Pransky G, Schoene M, Sieper J, Smeets RJ, Turner JA, Woolf A. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet 2018;391:2368–83.
Franklin GM, Rahman EA, Turner JA, Daniell WE, Fulton-Kehoe D. Opioid use for chronic low back pain: a prospective, population-based study among injured workers in Washington state, 2002-2005. Clin J Pain 2009;25:743–51.
Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM; Risk Identification Study C. Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort. Spine 2008;33:199–204.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789–858.
Graves JM, Fulton-Kehoe D, Jarvik JG, Franklin GM. Impact of an advanced imaging utilization review program on downstream health care utilization and costs for low back pain. Med Care 2018;56:520–8.
Gross DP, Stephens B, Bhambhani Y, Haykowsky M, Bostick GP, Rashiq S. Opioid prescriptions in Canadian workers' compensation claimants: prescription trends and associations between early prescription and future recovery. Spine 2009;34:525–31.
Haffajee RL. Prescription drug monitoring programs—friend or folly in addressing the opioid-overdose crisis? N Engl J Med 2019;381:699–701.
Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analgesia 2017;125:1733–40.
Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karppinen J, Pransky G, Sieper J, Smeets RJ, Underwood M, Buchbinder R, Hartvigsen J, Cherkin D, Foster NE, Maher CG, Underwood M, van Tulder M, Anema JR, Chou R, Cohen SP, Menezes Costa L, Croft P, Ferreira M, Ferreira PH, Fritz JM, Genevay S, Gross DP, Hancock MJ, Hoy D, Karppinen J, Koes BW, Kongsted A, Louw Q, Öberg B, Peul WC, Pransky G, Schoene M, Sieper J, Smeets RJ, Turner JA, Woolf A. What low back pain is and why we need to pay attention. Lancet 2018;391:2356–67.
International Labour Organization (ILO). World social protection report 2017-19—Universal social protection to achieve the sustainable development goals. Geneva, Switzerland: ILO, 2017.
Koenker R. Quantile regression: 40 years on. Annu Rev Econ 2017;9:155–76.
Koenker R. Package 'quantreg'. Canada: The Comprehensive R Archive Network (CRAN), 2020.
Koenker R, Hallock KF. Quantile regression. J Econ Perspect 2001;15:143–56.
Lavin RA, Tao XG, Yuspeh L, Bernacki EJ. Impact of the combined use of benzodiazepines and opioids on workers' compensation claim cost. J Occup Environ Med 2014;56:973–8.
Lee J, Gupta S, Price C, Baranowski AP. Low back and radicular pain: a pathway for care developed by the British Pain Society. Br J Anaesth 2013;111:112–20.
Lippel K, Lötters F. Public insurance systems: a comparison of cause-based and disability-based income support systems. In: Loisel P, Anema JR, editors. Handbook of work disability: prevention and management. New York, NY: Springer, 2013. p. 183–202.
Martin J, Cunliffe J, Décary-Hétu D, Aldridge J. Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: interrupted time series analysis. BMJ 2018;361:k2270.
Mathieson S, Maher CG, Ferreira GE, Hamilton M, Jansen J, McLachlan AJ, Underwood M, Lin C-WC. Deprescribing opioids in chronic non-cancer pain: systematic review of randomised trials. Drugs 2020;80:1563–76.
Mathieson S, Wertheimer G, Maher CG, Christine Lin CW, McLachlan AJ, Buchbinder R, Pearson SA, Underwood M. What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies. J Intern Med 2020;287:458–74.
Microsoft Corporation. Microsoft visual studio 2017. Redmond, Washington: Microsoft Corporation, 2018.
Nagin D. Group-based modeling of development. Cambridge, MA: Harvard University Press, 2005.
Nagin DS. Group-based trajectory modeling: an overview. Ann Nutr Metab 2014;65:205–10.
Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 2010;6:109–38.
National Institute for Health and Care Excellence (NICE). Low back pain and sciatica in over 16s: assessment and management. London, UK: NICE, 2016.
Nielsen JD. Package 'crimCV'. Canada: The Comprehensive R Archive Network (CRAN), 2018.
Nielsen JD, Rosenthal JS, Sun Y, Day DM, Bevc I, Duchesne T. Group-based criminal trajectory analysis using cross-validation criteria. Commun Stat Theor Methods 2014;43:4337–56.
Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American college of physicians. Ann Intern Med 2017;166:514–30.
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2017.
Rhodes E, Wilson M, Robinson A, Hayden JA, Asbridge M. The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review. BMC Health Serv Res 2019;19:784.
Safe Work Australia (SWA). Comparison of workers' compensation arrangements in Australia and New Zealand 2013. Canberra, Australia: SWA, 2013.
Safe Work Australia (SWA). Comparison of workers' compensation arrangements in Australia and New Zealand 2018. Canberra, Australia: Safe Work Australia, 2018.
Services VGDoHH. SafeScript for patients and familes. Vol. 2020. Melbourne, Australia: Victorian Government, 2020.
Shraim M, Cifuentes M, Willetts JL, Marucci-Wellman HR, Pransky G. Length of disability and medical costs in low back pain: do state workers' compensation policies make a difference? J Occup Environ Med 2015;57:1275–83.
Shraim M, Cifuentes M, Willetts JL, Marucci-Wellman HR, Pransky G. Regional socioeconomic disparities in outcomes for workers with low back pain in the United States. Am J Ind Med 2017;60:472–83.
Steenstra IA, Munhall C, Irvin E, Oranye N, Passmore S, Van Eerd D, Mahood Q, Hogg-Johnson S. Systematic review of prognostic factors for return to work in workers with sub acute and chronic low back pain. J Occup Rehabil 2017;27:369–81.
Vadhariya A, Fleming ML, Johnson ML, Essien EJ, Serna O, Esse T, Choi J, Boklage SH, Abughosh SM. Group-based trajectory models to identify sociodemographic and clinical predictors of adherence patterns to statin therapy among older adults. Am Health Drug Benefits 2019;12:202–11.
Volinn E, Fargo JD, Fine PG. Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. PAIN 2009;142:194–201.
Webster BS, Cifuentes M, Verma S, Pransky G. Geographic variation in opioid prescribing for acute, work-related, low back pain and associated factors: a multilevel analysis. Am J Ind Med 2009;52:162–71.
Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine 2007;32:2127–32.
Wickizer TM, Franklin G, Fulton-Kehoe D, Gluck J, Mootz R, Smith-Weller T, Plaeger-Brockway R. Improving quality, preventing disability and reducing costs in workers' compensation healthcare: a population-based intervention study. Med Care 2011;49:1105–11.
World Health Organisation (WHO) Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2020. Vol. 2019. Oslo, Norway: Norwegian Institute of Public Health, 2019.
Xia T, Iles R, Newnam S, Lubman D, Collie A. Driving health study report no 4: use of pharmaceuticals following work-related injury and illness in Australian truck drivers. Melbourne, Australia: Insurance Work and Health Group, Faculty of Medicine Nursing and Health Sciences, Monash University, 2019.